223 related articles for article (PubMed ID: 37369559)
1. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
[TBL] [Abstract][Full Text] [Related]
2. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/- and human SCN5A-1795insD+/- iPSC-derived cardiomyocytes.
Portero V; Casini S; Hoekstra M; Verkerk AO; Mengarelli I; Belardinelli L; Rajamani S; Wilde AAM; Bezzina CR; Veldkamp MW; Remme CA
Cardiovasc Res; 2017 Jun; 113(7):829-838. PubMed ID: 28430892
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
[TBL] [Abstract][Full Text] [Related]
4. Chronic Mexiletine Administration Increases Sodium Current in Non-Diseased Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Nasilli G; Verkerk AO; O'Reilly M; Yiangou L; Davis RP; Casini S; Remme CA
Biomedicines; 2024 May; 12(6):. PubMed ID: 38927420
[TBL] [Abstract][Full Text] [Related]
5. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
[TBL] [Abstract][Full Text] [Related]
6. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
[TBL] [Abstract][Full Text] [Related]
7. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
[TBL] [Abstract][Full Text] [Related]
8. Differential calcium sensitivity in Na
Abdelsayed M; Baruteau AE; Gibbs K; Sanatani S; Krahn AD; Probst V; Ruben PC
J Physiol; 2017 Sep; 595(18):6165-6186. PubMed ID: 28734073
[TBL] [Abstract][Full Text] [Related]
9. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.
Nieto-Marín P; Tinaquero D; Utrilla RG; Cebrián J; González-Guerra A; Crespo-García T; Cámara-Checa A; Rubio-Alarcón M; Dago M; Alfayate S; Filgueiras-Rama D; Peinado R; López-Sendón JL; Jalife J; Tamargo J; Bernal JA; Caballero R; Delpón E;
Cardiovasc Res; 2022 Mar; 118(4):1046-1060. PubMed ID: 33576403
[TBL] [Abstract][Full Text] [Related]
10. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
11. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
[TBL] [Abstract][Full Text] [Related]
12. Loss of sodium current caused by a Brugada syndrome-associated variant is determined by patient-specific genetic background.
Martínez-Moreno R; Carreras D; Sarquella-Brugada G; Pérez GJ; Selga E; Scornik FS; Brugada R
Heart Rhythm; 2024 Mar; 21(3):331-339. PubMed ID: 38008367
[TBL] [Abstract][Full Text] [Related]
13. Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells.
Ma D; Wei H; Zhao Y; Lu J; Li G; Sahib NB; Tan TH; Wong KY; Shim W; Wong P; Cook SA; Liew R
Int J Cardiol; 2013 Oct; 168(6):5277-86. PubMed ID: 23998552
[TBL] [Abstract][Full Text] [Related]
14. Multiple mechanisms underlie increased cardiac late sodium current.
Kroncke BM; Yang T; Roden DM
Heart Rhythm; 2019 Jul; 16(7):1091-1097. PubMed ID: 30677491
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic Hit to Lead Refinement in a Dish Using Patient-Derived iPSC Cardiomyocytes.
Cashman JR; Ryan D; McKeithan WL; Okolotowicz K; Gomez-Galeno J; Johnson M; Sampson KJ; Kass RS; Pezhouman A; Karagueuzian HS; Mercola M
J Med Chem; 2021 May; 64(9):5384-5403. PubMed ID: 33942619
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach.
Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B
Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies.
Stutzman MJ; Gao X; Kim M; Ye D; Zhou W; Tester DJ; Giudicessi JR; Shannon K; Ackerman MJ
Heart Rhythm; 2023 May; 20(5):709-717. PubMed ID: 36731785
[TBL] [Abstract][Full Text] [Related]
18. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
[TBL] [Abstract][Full Text] [Related]
19. Switch From Fetal to Adult
Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.
Cheng J; Valdivia CR; Vaidyanathan R; Balijepalli RC; Ackerman MJ; Makielski JC
J Mol Cell Cardiol; 2013 Aug; 61():102-10. PubMed ID: 23541953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
